UCL Institute of Clinical Trials and Methodology


Postgraduate research

The UCL Institute of Clinical Trials and Methodology is a centre of excellence for clinical trials, meta-analysis and epidemiological studies.

Why UCL?


  • UCL is winner of The Times and Sunday Times University of the Year 2024
  • UCL is rated 9th in the QS World Rankings 2025
  • UCL is ranked 6th in the world for Public Health (ShanghaiRanking’s 2023)
  • UCL is No.1 for research power and impact in medicine, health and life sciences (REF 2021)
  • The combined strength of our four clinical trials units means The UCL Institute of Clinical Trials and Methodology has the largest group of trialists – approximately 400 - in Europe. Our institute is a centre of excellence for clinical trials, meta-analysis and epidemiological studies 
  • Our students are closely integrated into our community through research-embedded teaching

Browse our programmes 

For full programme information including modules, fees and entry requirements please visit the prospectus

Current PhD Studentships

MRC-NIHR Trials Methodology Research Partnership (TMRP) Doctoral Training Programme

We are pleased to be able to offer up to two fully funded studentships which will be based at the MRC Clinical Trials Unit at UCL, through the MRC-NIHR Trials Methodology Research Partnership (TMRP) Doctoral Training Programme. Full details, including available studentships and how to apply are available on the TMRP DTP website.

Current Projects

Increasing impact of non-industry drug clinical trials through experience with regulatory submission.

Late-phase clinical trials can impact on clinical practice & improve outcomes for patients. For industry-led trials of drugs & devices, the pathway to impact is clear: develop & run trials of healthcare interventions that can be submitted for regulatory review leading, if successful, to a new or extended license. However, industry does not do trials of all healthcare interventions; so many late-phase RCTs are developed and run by non--industry groups (academia, charities, government agencies) - sometimes involving collaboration with industry partners. Our prior research has shown that very few of these trials are used in regulatory submissions.

The objective of this PhD studentship is to enhance the “pathway to impact” for non-industry led trials -  by analysing factors in their design, conduct, & analysis that may hinder their delivery or the use of their results. By extracting valuable insights from the experiences of these trials and those who lead them, which can be applied to other (primarily ‘non-industry’) trials, we can increase their use in decision-making by regulatory bodies & guideline committees. Lessons learned and outcomes from this research has the potential for widespread impact on the execution of current and future clinical trials.

For more information on the project, the supervisors and how to apply please visit the studentship page on FindAPhD.com.

Patient and Public Involvement in late-phase clinical trials testing multiple primary research questions.

To find out more about the MRC-NIHR Trials and Methodology Research Partnership Doctoral Training Partnership (TMRP DTP) visit the TMRP DTP website.

For more information on entry requirements, how to apply and fees and funding for Postgraduate Research at ICTM, see our Clinical Trials and Methodology MPhil/PhD prospectus page.

Contact us

Clinical Trials and Methodology MPhil/PhD

E: ictm.researchdegrees@ucl.ac.uk